✓ No loaded language, vague sourcing, or framing detected.
Proximal Ventures, led by Sahir Raoof, has raised $27.5 million to invest in startups focused on applying AI in drug development. The fund aims to support innovation in the pharmaceutical sector.
Our neutral summary
Proximal Ventures, led by Sahir Raoof, has raised $27.5 million to invest in startups focused on applying AI in drug development. The fund aims to support innovation in the pharmaceutical sector.
The reporting belongs to TechCrunch; we don't reproduce it.
Notes are private: only you can see them.
No note attached
of yours on this article.
Proximal Ventures raises debut fund to back startups bringing AI to drug development
Proximal Ventures raises $27.5 million fund for AI in drug development